MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
119 hedge funds and large institutions have $78.7M invested in Merrimack Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 15 closing their positions.
Holders
119
Holders Change
+3
Holders Change %
+2.59%
% of All Funds
2.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
36
Closed
15
Calls
$242K
Puts
$473K
Net Calls
-$231K
Net Calls Change
+$1.22M
Top Buyers
1 |
1
Millennium Management
New York
|
$1.07M |
2 |
2
Morgan Stanley
New York
|
$758K |
3 |
JGC
3
J. Goldman & Co
New York
|
$331K |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.63M |
5 |
AL
5
Airain Ltd
St. Peter Port,
Guernsey
|
$292K |